APRISO(TM) Granted FDA Marketing Approval for Maintenance of … - WELT ONLINE
Monday, December 1st, 2008|
APRISO(TM) Granted FDA Marketing Approval for Maintenance of …
WELT ONLINE, Germany - Oct 31, 2008 APRISO is a locally-acting aminosalicylate indicated for the maintenance of remission of ulcerative colitis (UC) in adults. APRISO is the first and only … |